Publikationen

2020

A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A

Graf L, Yan S, Shen MC, Balasa V

J Med Econ. 2020 Sep 24:1
doi: 10.1080/13696998.2020.1828092

PDF

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on

Korte W, Buljan M, Rösslein M, Wick P, Golubov V, Jentsch J, Reut M, Peier K, Nohynek B, Fischer A, Stolz R, Cettuzzi M, Nolte O

J Infect. 2020 Aug 24:S0163-4453(20)30567-3
doi: 10.1016/j.jinf.2020.08.032

PDF

The Need for Red Cell Support During Non-Cardiac Surgery Is Associated to Pre-Transfusion Levels of FXIII and the Platelet Count

Listyo S, Forrest E, Graf L, Korte W

J Clin Med. 2020 Jul 31;9(8):E2456
doi: 10.3390/jcm9082456

PDF

Bleeding risks for uncharacterized platelet function disorders

Brunet J, Badin M, Chong M, Iyer J, Tasneem S, Graf L, Rivard GE, Paterson AD, Pare G, Hayward CPM

Res Pract Thromb Haemost. 2020 May 30;4(5):799-806
doi: 10.1002/rth2.12374

PDF

Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland

Alberio L, Angelillo-Scherrer A, Asmis L, Casini A, Fontana P, Graf L, Hegemann I, Kremer Hovinga JA, Korte W, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris DA, Wuillemin WAlberio L, Angelillo-Scherrer A, Asmis L, Casini A, Fontana P, Graf L, Hegemann I, Kremer Hovinga JA, Korte W, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris DA, Wuillemin WAlberio L, Angelillo-Scherrer A, Asmis L, Casini A, Fontana P, Graf L, Hegemann I, Kremer Hovinga JA, Korte W, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris DA, Wuillemin W

Swiss Med Wkly. 2020 Apr 24;150:w20210
doi: 10.4414/smw.2020.20210

PDF

Associations between self-reported sleep duration and cardiometabolic risk factors in young African-origin adults from the five-country Modeling the Epidemiologic Transition Study (METS)

Rae DE, Dugas L, Roden L, Lambert EV, Bovet P, Plange-Rhule J, Forrester T, Riesen W, Korte W, Crowley S, Reutrakul S, Luke A

Sleep Health. 2020 Apr 19:S2352-7218(20)30101-7
doi: 10.1016/j.sleh.2020.03.003

PDF

Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19

Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber B, Graf L, Hegemann I, Korte W, Kremer Hovinga J, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris D, Wuillemin W, Asmis L

Swiss Med Wkly. 2020;150:w20247
doi:10.4414/smw.2020.20247

PDF

The impact of prepartum factor XIII activity on postpartum blood loss

Haslinger C, Korte W, Hothorn T, Brun R, Greenberg C, Zimmermann R

J Thromb Haemost. 2020 Mar 16
doi: 10.1111/jth.14795

PDF

Airway Obstruction Caused by Hemorrhage: Managing a Life-Threatening Complication in Patients With Acquired Hemophilia A: A Case Report

Endermann S, Korte W, Filipovic M

A A Pract. 2020 Feb 1;14(3):83-86
doi: 10.1213/XAA.0000000000001155

2019

Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry

Spirk D, Sebastian T, Banyai M, Beer JH, Mazzolai L, Baldi T, Aujesky D, Hayoz D, Engelberger RP, Kaeslin T, Korte W, Escher R, Husmann M, Mollet A, Szucs TD, Kucher N

Semin Thromb Hemost. 2019 Nov;45(8):851-858
doi: 10.1055/s-0039-1698770

Swiss Delphi study on iron deficiency

Nowak A, Angelillo-Scherrer A, Betticher D, Dickenmann M, Guessous I, Juillerat P, Korte W, Neuner-Jehle S, Pfister O, Surbek D, Battegay E, Steurer J

Swiss Med Wkly. 2019 Jul 3;149:w20097
doi: 10.4414/smw.2019.20097

PDF

The human microbiota is associated with cardiometabolic risk across the epidemiologic transition

Fei N, Bernabé BP, Lie L, Baghdan D, Bedu-Addo K, Plange-Rhule J, Forrester TE, Lambert EV, Bovet P, Gottel N, Riesen W, Korte W, Luke A, Kliethermes SA, Layden BT, Gilbert JA, Dugas LR

PLoS One. 2019 Jul 24;14(7)
doi: 10.1371/journal.pone.0215262

PDF

First clinical case of KPC-3-producing Klebsiella michiganensis in Europe.

Seiffert SN, Wüthrich D, Gerth Y, Egli A, Kohler P, Nolte O

New Microbes New Infect. 2019 Feb 23;29:100516.
doi: 10.1016/j.nmni.2019.100516.

PDF

NOACs in Anesthesiology

Spahn DR, Beer JH, Borgeat A, Chassot PG, Kern C, Mach F, Nedeltchev K, Korte W

Transfus Med Hemother
doi: 10.1159/000491 400

PDF

2018

Independent association of resting energy expenditure with blood pressure: confirmation in populations of the African diaspora

Creber C, Cooper RS, Plange-Rhule J, Bovet P, Lambert EV, Forrester TE, Schoeller D, Riesen W, Korte W, Cao G, Luke A, Dugas LR

BMC Cardiovasc Disord. 2018 Jan 10;18(1):4
doi: 10.1186/s12872-017-0737-5

PDF

Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients

Blondon M, Spirk D, Kucher N, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Bounameaux H, Righini M, Nendaz M

Thromb Haemost. 2018 Jan;118(1):82-89
doi: 10.1160/TH17-06-0403

PDF

Electron microscopy examination of platelet whole mount preparations to quantitate platelet dense granule numbers: Implications for diagnosing suspected platelet function disorders due to dense granule deficiency

Brunet JG, Iyer JK, Badin MS, Graf L, Moffat KA, Timleck M, Spitzer E, Hayward CPM

Int J Lab Hematol. 2018 Mar 6
doi: 10.1111/ijlh.12801

PDF

Extended Half-Life Factor VIII and Factor IX Preparations

Graf L

Transfus Med Hemother 2018;45:86–91
doi: 10.1159/000488060

PDF

Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016).

Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, Kühnert M, Lier H, Maul H, Rath W, Steppat S, Surbek D, Wacker J

Geburtshilfe Frauenheilkd. 2018 Apr;78(4):382-399
doi: 10.1055/a-0582-0122

PDF

Hemotherapy with New Blood Products

Korte W, Zeerleder S.S

Transfus Med Hemother 2018;45:84
doi: 10.1159/000488379

PDF

The Potential Close Future of Hemophilia Treatment - Gene Therapy, TFPI Inhibition, Antithrombin Silencing, and Mimicking Factor VIII with an Engineered Antibody

Korte W, Graf L

Transfus Med Hemother 2018;45:92-96
doi: 10.1159/000488152

PDF

THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents

Greiner J, Schrappe M, Claviez A, Zimmermann M, Niemeyer C, Kolb R, Eberl W, Berthold F, Bergsträsser E, Gnekow A, Lassay E, Vorwerk P, Lauten M, Sauerbrey A, Rischewski J, Beilken A, Henze G, Korte W, Möricke A

Haematologica. 2018 Sep 27. pii: haematol.2018.194175
doi: 10.3324/haematol.2018.194175

PDF

Independent association of resting energy expenditure with blood pressure: confirmation in populations of the African diaspora

Creber C, Cooper RS, Plange-Rhule J, Bovet P, Lambert EV, Forrester TE, Schoeller D, Riesen W, Korte W, Cao G, Luke A, Dugas LR

BMC Cardiovasc Disord. 2018 Jan 10;18(1):4
doi: 10.1186/s12872-017-0737-5

PDF

Familiäre Hypercholesterinämie - Diagnose und Therapie

Schöb M, Müller P, Gerth Y, Korte W, Rickli H, Brändle M, Bärlocher A, Bilz S

Praxis 2018;107(24):1345-1353
doi: 10.1024/1661-8157/a003134

PDF

Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab

Aeppli S, Driessen C, Graf L, Hitz F

Hematol Oncol. 2018 Oct;36(4):713-714
doi: 10.1002/hon.2533

2017

Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation

Badin MS, Iyer JK, Chong M, Graf L, Rivard GE, Waye JS, Paterson AD, Pare G, Hayward CP

Haemophilia. 2017 Feb 8
doi: 10.1111/hae.13169

PDF

Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit

von Rappard S, Hinnen C, Lussmann R, Rechsteiner M, Korte W

Transfus Med Hemother 2017;44:1–8
doi: 10.1159/000468946

PDF

Thrombosis in Inherited Fibrinogen Disorders

Korte W, Poon M-C, Iorio A, Makris M

Transfus Med Hemother 2017;44:1–7
doi: 10.1159/000452864

PDF

The new German guideline on postpartum haemorrhage (PPH): essential aspects for coagulation and circulatory therapy

Lier H, Schlembach D, Korte W, von Heymann C, Steppat S, Kühnert M, Maul H, Henrich W, Rath W, Wacker J, Kainer F, Surbek D, Helmer H

Anasthesiol Intensivmed Notfallmed Schmerzther. 2016 Sep;51(9):526-35
doi: 10.1055/s-0042-105937

Impact of rivaroxaban on point-of-care assays

Fontana P, Alberio L, Angelillo-Scherrer A, Asmis L, Korte W, Mednez A, Schmid P, Stricker H, Studt J, Tsakiris D, Wuillemin W, Nagler M

Thromb Res. 2017 May;153:65-70
doi: 10.1016/j.thromres.2017.03.019

Hemostasis and Hemotherapy

Korte W, Cattaneo M

Transfus Med Hemother 2017;44:68
doi: 10.1159/000471503

PDF

Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012

Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk CM, Arndt V

Cancer Epidemiol. 2017 Feb;46:85-92
doi: 10.1016/j.canep. 2016.12.005

Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study

Bulla O, Poncet A, Alberio L, Asmis LM, Gähler A, Graf L, Nagler M, Studt JD, Tsakiris DA, Fontana P

Haemophilia. 2017 May 24
doi: 10.1111/hae.13250

Cardiovascular risk status of Afro-origin populations across the spectrum of economic development: findings from the Modeling the Epidemiologic Transition Study

Dugas LR, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Durazo-Arvizu RA, Cao G, Cooper RS, Khatib R, Tonino L, Riesen W, Korte W, Kliethermes S, Luke A

BMC Public Health. 2017 May 12;17(1):438
doi: 10.1186/s12889-017-4318-4

PDF

In vitro and ex vivo Measurement of Prophylactic Dabigatran Concentrations with a New Ecarin-Based Thromboelastometry Test

Körber MK, Langer E, Köhr M, Wernecke KD, Korte W, von Heymann C

Transfus Med Hemother. 2017 Apr;44(2):100-105
doi: 10.1159/000470622

PDF

Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels

Studt JD, Alberio L, Angelillo-Scherrer A, Asmis LM, Fontana P, Korte W, Mendez A, Schmid P, Stricker H, Tsakiris DA, Wuillemin WA, Nagler M

J Thromb Haemost. 2017 Jun 2
doi: 10.1111/jth.13747

PDF

Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera

Meyer SC, Steinmann E, Lehmann T, Muesser P, Passweg J, Skoda R, Tsakiris DA

Biomed Res Int. 2017;2017:9876819
doi: 10.1155/2017/9876819

PDF

The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry

Alatri A, Mazzolai L, Kucher N, Aujesky D, Beer JH, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Escher R, Husmann M, Frauchiger B, Engelberger RP, Baumgartner I, Spirk D

Semin Thromb Hemost. 2017 Aug 4
doi: 10.1055/s-0037-1604086

PDF

Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage

Joswig H, Korte W, Früh S, Epprecht L, Hildebrandt G, Fournier JY, Stienen MN

Neurosurg Rev. 2017 Sep 10
doi: 10.1007/s10143-017-0900-6

PDF

Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review

Boehnel C, Rickli H, Graf L, Maeder MT

Catheter Cardiovasc Interv. 2017 Sep 12
doi: 10.1002/ccd.27255

PDF

Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline

Lier H, von Heymann C, Korte W, Schlembach D

Transfus Med Hemother 2017;44:1–9
doi: 10.1159/000478106

PDF

2016

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease

Geyer H, Scherber R, Kosiorek H, Dueck AC, Kiladjian JJ, Xiao Z, Slot S,Zweegman S, Sackmann F, Fuentes AK, Hernández-Maraver D, Döhner K, Harrison CN, Radia D, Muxi P, Besses C, Cervantes F, Johansson PL, Andreasson B, Rambaldi A, Barbui T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L,Cahn JY, Maldonado N, Barosi G, Ferrari ML, Gale RP, Birgegard G, Xu Z, Zhang Y,Sun X, Xu J, Zhang P, te Boekhorst PA, Commandeur S, Schouten H, Pahl HL, Griesshammer M, Stegelmann F, Lehmann T, Senyak Z, Vannucchi AM, Passamonti F,Samuelsson J, Mesa RA

J Clin Oncol. 2016 Jan 10;34(2):151-9
doi: 10.1200/JCO.2015.62.9337

PDF

Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER)

Kucher N, Aujesky D, Beer JH, Mazzolai L, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Escher R, Husmann M, Frauchiger B, Baumgartner I, Spirk D

Thromb Haemost. 2016 Aug 30;116(3):472-9
doi: 10.1160/TH16-03-0209

Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER)

Spirk D, Aujesky D, Stuck AK, Beer JH, Mazzolai L, Baldi T, Banyai M, Hayoz D, Kaeslin T, Korte W, Robert E, Husmann M, Frauchiger B, Baumgartner I, Kucher N

Semin Thromb Hemost. 2016 Sep;42(6):642-9
doi: 10.1055/s-0036-1584131

Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder

Badin MS, Graf L, Iyer JK, Moffat KA, Seecharan JL, Hayward CP

Int J Lab Hematol. 2016 Aug 30
doi: 10.1111/ijlh.12553

The PiCT(®)test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study

Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W

J Thromb Haemost. 2016 Sep 1
doi: 10.1111/jth.13489

PDF

The social patterning of risk factors for noncommunicable diseases in five countries: evidence from the modeling the epidemiologic transition study (METS)

Stringhini S, Forrester TE, Plange-Rhule J, Lambert EV, Viswanathan B, Riesen W, Korte W, Levitt N, Tong L, Dugas LR, Shoham D, Durazo-Arvizu RA, Luke A, Bovet P

BMC Public Health. 2016 Sep 9;16(1):956
doi: 10.1186/s12889-016-3589-5

PDF

Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data

Solomon C, Korte W, Fries D, Pendrak I, Joch C, Gröner A, Birschmann I

Transfus Med Hemother. 2016 Sep;43(5):365-373
doi: 10.1159/000446813

PDF

Interview: Aktualisierung der AWMFS3- Leitlinie zur VTE-Prophylaxe

Korte W

Leading Opinions, Hämatologie & Onkologie, 2016 Feb 25

Die neue deutsche Leitlinie zur peripartalen Hämorrhagie-Wichtige Aspekte für die Gerinnungsund Kreislauftherapie

Lier H, Schlembach D, Korte W, von Heymann Ch

AINS-Anästhesiologie· Intensivmedizin· Notfallmedizin· Schmerztherapie 2016;51:526-35

PDF

Perioperatives Management der Antikoagulantien

Graf L, Korte W

Ther Umsch. 2016;73(10):545-549
doi: 10.1024/0040-5930/a000835

PDF

Peripartum Haemorrhage, Diagnosis and Therapy

Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, Kühnert M, Lier H, Maul H, Rath W, Steppat S, Surbek D, Wacker J

Geburtshilfe Frauenheilkd. 2018 Apr;78(4):382-399
doi: 10.1055/a-0582-0122

PDF

2015

Direkte orale Antikoagulantien und Medkiamenteninteraktionen

Graf L, Korte W

Therapeutische Umschau. 2015 Feb;72(2):99-104
doi: 10.1024/0040-5930/ a000650

PDF

A case of Capnocytophaga canimorsus sacral abscess in an immunocompetent patient

Joswig H, Gers B, Dollenmaier G, Heilbronner R, Strahm C

Infection. 2015 Apr;43(2):217-21
doi: 10.1007/s15010-014-0681-6

PDF

Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

Dickneite G, Herwald H, Korte W, Allanore Y, Denton CP, Matucci Cerinic M

Thromb Haemost. 2015 Apr;113(4):686-97
doi: 10.1160/TH14-07-0625

PDF

Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE)

Spirk D, Nendaz M, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Righini M, Bounameaux H, Kucher N

Thromb Haemost. 2015 May;113(5):1127-34
doi: 10.1160/TH14-06-0525

Gallbladder perforation and massive intraabdominal haemorrhage complicating acute cholecystitis in a patient with haemophilia A

Mechera R, Graf L, Oertli D, Viehl CT

BMJ Case Rep. 2015 May 2;2015
doi: 10.1136/bcr-2014-205971

PDF

Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage

Sigle JP, Holbro A, Lehmann T, Infanti L, Gerull S, Stern M, Tichelli A,Passweg J, Buser A

Am J Clin Pathol. 2015 Jul;144(1):145-50
doi: 10.1309/AJCPN7L9RTTP NNRW

PDF

Erythropoietin receptor mutation a rush of blood to the head?

Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T

Ann Hematol. 2015 Jul;94(7):1229-31
doi: 10.1007/s00277-015-2346-7

Acute Hepatitis E Infection with coincident reactivation of EBV infection in an immunsuppressed patient with rheumatoid arthritis: a case report

Schultze D, Mani B, Dollenmeier G, Sahli R, Zbinden A,Krayenbühl PA

BMC Infect Dis. 2015 Oct 29;15:474
doi: 10.1186/s12879-015-1146-y

PDF

Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells

Göckeritz E, Kerwien S, Baumann M, Wigger M, Vondey V, Neumann L, Landwehr T, Wendtner CM, Klein C, Liu N, Hallek M, Frenzel LP, Krause G

Int J Cancer. 2015 Nov 1;137(9): 2234-42
doi: 10.1002/ijc.29579

PDF

Thrombophile Faktoren und der sinnvolle Einsatz der Labordiagnostik

Graf L, Korte W

Cardiovasc 2015; Vol. 14, Nr. 2

2014

Complement factor concentrations in patients with acute myocardial infarction: time course and ability to predict left ventricular dysfunction

Brenner R, Maeder MT, Trachsel L, Ammann P, Rickli H, Korte W

Biomark Med. 2014;8(2):247-58
doi: 10.2217/bmm.13.111

Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE)

Nendaz M, Spirk D, Kucher N, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Jäger K, Righini M, Bounameaux H

Thromb Haemost. 2014 Mar 3;111(3):531-8
doi: 10.1160/TH13-05-0427

Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis

Nesin V, Wiley G, Kousi M, Ong EC, Lehmann T, Nicholl DJ, Suri M, Shahrizaila N, Katsanis N, Gaffney PM, Wierenga KJ, Tsiokas L

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4197-202
doi: 10.1073/pnas. 1312520111

PDF

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC

Blood. 2014 Apr 3;123(14):2220-8
doi: 10.1182/blood-2013-11-537167

PDF

Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations

Song HK, von Heymann C, Jespersen CM, Karkouti K, Korte W, Levy JH, Ranucci M, Saugstrup T, Sellke FW

Ann Thorac Surg. 2014 May;97(5):1630-5
doi: 10.1016/j.athoracsur. 2013.12.025

PDF

Myelofibrose

Schneider T, Lehmann T

Leading Opinions- Innere Medizin. 2014;2: 56-9

Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment

Holbro A, Graf L, Topalidou M, Bucher C, Passweg JR, Tsakiris DA

Transfusion. 2014 Jun;54(6):1508-14
doi: 10.1111/trf.12511

Harmless bruises? Coagulopathy despite normal INR

Greuter L, Schöb M, Lehmann T, Diethelm M

Praxis (Bern 1994). 2014 Jul 23;103(15):899-902
doi: 10.1024/1661-8157/ a001727

PDF

Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges

Hayward CP, Moffat KA, Graf L

Int J Lab Hematol.2014 Jun;36(3):334-40
doi: 10.1111/ijlh.12220

PDF

Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin

Graf L, Moffat KA, Carlino SA, Chan AK, Iorio A, Giulivi A, Hayward CP

Int J Lab Hematol. 2014 Jun;36(3):341-51
doi: 10.1111/ijlh.12218

PDF

Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?

Korte W

J Blood Med. 2014 Jul 9;5:107-13
doi: 10.2147/JBM.S35395. eCollection 2014

PDF

Outcome measures in haemophilia: a systematic review

Boehlen F, Graf L, Berntorp E

Eur J Haematol Suppl. 2014 Aug;76:2-15
doi: 10.1111/ejh.12369

PDF

Massive human rivaroxaban overdose

Lehmann T, Hofer KE, Baumann M, Hasler K, Ceschi A, Kupferschmidt H, Rohde G, Korte W

Thromb Haemost. 2014 Oct;112(4):834-6
doi: 10.1160/TH14-02-0138

PDF

Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests

Vetter BN, Orlowski V, Fransen K, Niederhauser C, Aubert V, Brandenberger M, Ciardo D, Dollenmaier G, Klimkait T, Regenass S, Schmid P, Schottstedt V, Suter-Riniker F, Yerly S, Shah C, Böni J, Schüpbach J

PLoS One. 2014 Oct 24;9(10):e111552
doi: 10.1371/journal. pone.0111552

PDF

Bridging der oralen Antikoagulation

Korte W, Graf L

Der informierte Arzt. 2014;9

PDF

2013

Non-cirrhotic portal hypertension with nearly lethal consequences

Börner N, Korte W, Doenecke C, Pfister M, Meyenberger C, Semela D, Sawatzki M

Praxis (Bern 1994). 2013 May 22;102(11):681-5
doi: 10.1024/1661-8157/a001303

PDF

Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial

Bucher CM, Lehmann T, Tichelli A, Tzankov A, Dirnhofer S, Passweg J, Rovó A

J Clin Pathol. 2013 Jan;66(1):24-8
doi: 10.1136/jclinpath-2012-201167

PDF

JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report

Girsberger S, Karow A, Lundberg P, Dirnhofer S, Lehmann T, Passweg JR, Tichelli A, Skoda R, Rovó A

Acta Haematol. 2013;129(1):23-5
doi: 10.1159/000342100

Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study

Nagler M, Bachmann LM, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Reber G, Stricker H, Tsakiris DA, Wuillemin WA

Thromb J. 2013 Mar 7;11(1):6
doi: 10.1186/1477-9560-11-6

PDF

Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors

Templeton AJ, Thürlimann B, Baumann M, Mark M, Stoll S, Schwizer M, Dietrich D, Ruhstaller T

BMC Cancer.2013 Mar 25;13:153
doi: 10.1186/1471-2407-13-153

PDF

Advancing haemostasis automation - successful implementation of robotic centrifugation and sample processing in a tertiary service hospital. Clinical chemistry and laboratory medicine

Sédille-Mostafaie N, Engler H, Lutz S, Korte W

Clin Chem Lab Med. 2013 Jun;51(6):1273-8
doi: 10.1515/cclm-2012-0625

PDF

Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg JR, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter JP, Tamm M

Biol Blood Marrow Transplant. 2013 Jun;19(6):973-80
doi: 10.1016/j.bbmt. 2013.03.017

Schnellteste für A-Streptokokken und Influenza-Viren

Schultze D

Der Informierte Arzt. 2013;3

PDF

Einsatz von konventionellen NSARs und Coxiben bei Risikopatienten

Ruschitzka F, Korte W, Vavricka ST, Widler J

Hausarzt Praxis. 2013;7: 4-6

Questions et réponses sur l’utilisation du rivaroxaban (Xarelto) dans la pratique

Wuillemin WA, Alberio LA, Angelillo- Scherrer A, Huber A, Tsakiris DA, Asmis LM, Fontana P, Korte W, Mendez A, Reber G, Stricker H, Studt JD

Rev Med Suisse. 2013; 9:1375- 85

PDF

Heparininduzierte Thrombozytopenie und perioperatives Management der antithrombotischen Therapie

Tsakiris DA, Korte W, Fontana P

Schweiz Med Forum. 2013;13(36):692–95

PDF

Etodolac does not inhibit platelet aggregation

Zoller N, Gähler A, Degiacomi P, Korte W

New developments in chemistry

PDF

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial

Karkouti K, von Heymann C, Jespersen CM, Korte W, Levy JH, Ranucci M, Sellke FW, Song HK

J Thorac Cardiovasc Surg. 2013 Oct;146(4):927-39
doi: 10.1016/j.jtcvs.2013.04.044

PDF

Peri- und intraoperative Gerinnungsstörungen und ihre Therapieempfehlungen

Korte W

Viszeralmedizin. 2013;29:303–10
doi: 10.1159/000356071

PDF

Frühes und tiefes Ansprechen sowie präzisere Identifizierung von Hochrisikopatienten mit CML

Lehmann T

Leading Opinions- Hämatologie & Onkologie. 2013; 4: 30-1

2012

Novel oral anticoagulants: new challenges for anesthesiologists in bleeding patients

Spahn DR, Korte W

Anesthesiology. 2012 Jan;116(1):9-11
doi: 10.1097/ALN. 0b013e318238c070

PDF

Rivaroxaban: Quantification by anti-Fxa assay and influence on coagulation tests: a study in 9 Swiss laboratories

Asmis LM, Alberio L, Angelillo-Scherrer A, Korte W, Mendez A, Reber G, Seifert B, Stricker H, Tsakiris DA, Wuillemin WA

Thromb Res. 2012 Apr;129(4):492-8
doi: 10.1016/j.thromres. 2011.06.031

Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection

Schüpbach J, Bisset LR, Gebhardt MD, Regenass S, Bürgisser P, Gorgievski M, Klimkait T, Andreutti C, Martinetti G, Niederhauser C, Yerly S, Pfister S, Schultze D, Brandenberger M, Schöni-Affolter F, Scherrer AU, Günthard HF; Swiss HIV Cohort Study

BMC Infect Dis. 2012 Apr 12;12:88
doi: 10.1186/1471-2334-12-88

PDF

Long term continuous positive airway pressure (CPAP) decreases tumor necrosis factor alpha but not visceral fat in men with obstructive sleep apnea syndrome

Hegglin A, Korte W, Schoch OD, Hahn K, Hürny C, Münzer T

Sleep Medicine. 2012 Jun;16(2): 405-12

Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome

Hegglin A, Schoch OD, Korte W, Hahn K, Hürny C, Münzer T

Sleep Breath. 2012 Jun;16(2):405-12
doi: 10.1007/s11325-011-0512-2

PDF

New anticoagulants for the prevention and therapy of venous thromboembolism- a review

Sédille-Mostafaie N, Korte W

Cardiovascular Medicine. 2012;15(5):147–54

PDF

Langerhans cell histiocytosis with central nervous system involvement--complete response to 2- chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib

Baumann M, Cerny T, Sommacal A, Koeberle D

Hematol Oncol. 2012 Jun;30(2):101-4
doi: 10.1002/hon.1005

Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis

Fenner L, Egger M, Bodmer T, Altpeter E, Zwahlen M, Jaton K, Pfyffer GE, Borrell S, Dubuis O, Bruderer T, Siegrist HH, Furrer H, Calmy A, Fehr J, Stalder JM, Ninet B, Böttger EC, Gagneux S; Swiss HIV Cohort Study and the Swiss Molecular Epidemiology of Tuberculosis Study Group

Antimicrob Agents Chemother. 2012 Jun;56(6):3047-53
doi: 10.1128/AAC.06460-11

PDF

First report of sandfly fever virus infection imported from Malta into Switzerland, October 2011

Schultze D, Korte W, Rafeiner P, Niedrig M

Euro Surveill. 2012 Jul 5;17(27)

PDF

Perioperative course of FXIII in children undergoing major surgery

Haas T, Korte W, Spielmann N, Mauch J, Madjdpour C, Schmugge M, Weiss M

Paediatr Anaesth. 2012 Jul;22(7):641-6
doi: 10.1111/j.1460-9592.2011.03709

Transvaginal access for NOTES: a cohort study of microbiological colonization and contamination

Linke GR, Tarantino I, Bruderer T, Celeiro J, Warschkow R, Tarr PE, Müller-Stich BP, Zerz A

Endoscopy. 2012 Jul;44(7):684-9
doi: 10.1055/s-0032-1309390

A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report

Schultze D, Müller B, Bruderer T, Dollenmaier G, Riehm JM, Boggian K

BMC Infect Dis. 2012 Oct 4;12:242
doi: 10.1186/1471-2334-12-242

PDF

Sunitinib - An Erythropoiesis Modulating Agent

Graf L, Gillessen S, Cerny T, Korte W

N ENGLJ MED 356;22 MAY31, 2007

PDF

State-of-the-Art in Hämostaseologie Teil 2

Korte W, Spannagl M

Hämostaseologie 2012;32(4):247-247

PDF

56. Jahrestagung der Gesellschaft für Thromboseund Hämostaseforschung e. V. (GTH) Joint Meeting GTH & Italian Associations of Haemostasis and Thrombosis

Korte W

Hämostaseologie 2012;32(1): 1-1

PDF

Diagnostik - Pfad "Abdominalschmerz"

Freidank H, Muser J, von Landenberg PH, von Eckardstein A, Walz B, Balmelli T, Buhl D, Korte W, Conrad W, Huber A

Forum Med Suisse. 2012;12(14–15):310–11

PDF

Thrombophilidiagnostik - Entscheidungshilfe in komplexen Risikosituationen

Baumann M, Korte W

Cardiovasc 2012; 6:4-6

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs

Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA

J Clin Oncol. 2012 Nov 20;30(33):4098-103
doi: 10.1200/JCO.2012. 42.3863

PDF

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

Schwamb J, Feldhaus V, Baumann M, Patz M, Brodesser S, Brinker R, Claasen J, Pallasch CP, Hallek M, Wendtner CM, Frenzel LP

Blood. 2012 Nov 8;120(19):3978-85
doi: 10.1182/blood-2012-05-431783

PDF

BCR-ABL1-negative Myeloproliferative Neoplasie

Cantoni N, Passweg JR, Lehmann T

info@onkologie 2012;3:10-14

PDF

Myeloproliferative Neoplasien, klinische Relevanz neuer Mutationen

Lehmann T, Passweg JR

info@onkologie 2012;3:15-17

PDF

Performance evaluation of the Access FT3 and FT4 assays, comparison with Immulite and AxSym, and the relationship to TSH values

Korte W, Engler H, Riesen WF, Brinkmann T

Clin Lab. 2012;58(7-8):645-57

PDF

2011

Empfehlungen für Diagnose und Behandlung der chronischen lymphatischen Leukämie in der Schweiz Teil 1: Diagnose, Staging und Prognosefaktoren Teil 2: Therapieindikationen und Therapiestrategien

Gregor M, Bargetzi M, Duchosal MA, Goede JS, Heim D, Helg C, Korte W, Leoncini L, Solenthaler M, Zenhäusern R

Schweiz Med Forum. 2011;11(6),93-7 ;11(7)118-24

PDF

Effectiveness of a new decolonisation regimen for eradication of extended-spectrum ?-lactamaseproducing Enterobacteriaceae

Buehlmann M, Bruderer T, Frei R, Widmer AF

J Hosp Infect. 2011 Feb;77(2):113-7
doi: 10.1016/j.jhin.2010.09.022

Molecular surveillance of circulating dengue genotypes through European travelers

Domingo C, Niedrig M, Gascón J, Palacios G, Reyes N, Malo MJ, Wichmann O, Ruiz J, Schultze D, Schunk M, Puente S, Vinner L, Van Esbroeck M, Schuffenecker I, Grandadam M, López-Vélez R, Tenorio A

J Travel Med. 2011 May-Jun;18(3):183-90
doi: 10.1111/j.1708-8305. 2011.00501

PDF

Peri-operative management of antiplatelet therapy in patients with coronary artery disease

Korte W, Cattaneo M, Chassot PG, Eichinger S, von Heymann C, Hofmann N, Rickli H, Spannagl M, Ziegler B, Verheugt F, Huber K

Thromb Haemost. 2011 May;105(5):743-9
doi: 10.1160/TH10-04-0217

PDF

Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II

Spirk D, Ugi J, Korte W, Husmann M, Hayoz D, Baldi T, Frauchiger B, Banyai M, Aujesky D, Baumgartner I, Kucher N

Thromb Haemost. 2011 Jun;105(6):962-7
doi: 10.1160/TH11-01-0002

PDF

Periinterventionelles Management der Antikoagulation und Antiaggregation

Nagler M, Erne P, Babst R, Korte W, Wuillemin WA

Schweiz Med Forum. 2011;11(23-24):407-12

PDF

Chronische Lymphatische Leukämie (CLL) - Von Faszination und Meilensteinen

Baumann M

info@onkologie 2011;6-10

PDF

An international collaborative study to establish the WHO 1st international standards for C1-inhibitor, plasma and concentrate

Thelwel C, Rigsby P, Longstaff C; ISTH-SSC Subcommittee on Factor XI and Contact System

J Thromb Haemost. 2011 Oct;9(10):2097-9
doi: 10.1111/j.1538-7836.2011.04455

PDF

Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers

Huober J, Baumann M, Rochlitz C, Aebi S, Güth U, von Moos R, Müller A, von Rohr L, Widmer I, Thürlimann B

Oncology. 2011;81(3-4):160-6
doi: 10.1159/000333396

Autoantibodies against inosine-5'-monophosphate dehydrogenase 2-characteristics and prevalence in patients with HCV-infection

Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M

Clin Lab. 2011;57(9-10):753-65

Diagnostische Pfade im Krankenhaus

Freidank H, Balmelli T, Buhl D, Conrad W, von Eckardstein A, Huber A, Korte W, von Landenberg PH, Muser J, Walz B

Schweiz Med Forum. 2011; 11(36): 603

PDF

Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections

Rampini SK, Bloemberg GV, Keller PM, Büchler AC, Dollenmaier G, Speck RF, Böttger EC

Clin Infect Dis. 2011 Dec;53(12):1245-51
doi: 10.1093/cid/cir692

PDF